Epiminder Ltd (ASX: EPI) — Company Overview, News & Financial Data
Epiminder Ltd is a medical technology company specializing in the development and commercialization of continuous long-term electroencephalography monitoring devices for epilepsy management.
Epiminder Ltd
Epiminder Ltd is a medical technology company specializing in the development and commercialization of continuous long-term electroencephalography monitoring devices for epilepsy management. The company's flagship product, the Minder system, is an implantable continuous EEG monitoring device designed to record long-term brain activity in patients with drug-resistant epilepsy. By capturing neural signals over extended periods ranging from months to years, the system provides objective data on seizure frequency and pattern to assist clinicians in treatment planning and patient care. Headquartered in Melbourne, Australia, the company conducts clinical studies and research to advance digital health and neurotech solutions in neurology.
Snapshot
Operations
Products and/or services of Epiminder Ltd
- continuous brain monitoring devices: Development and provision of sub-scalp implantable continuous electroencephalography monitoring devices designed to capture long-term neural activity in adult patients suffering from drug-resistant epilepsy to support improved clinical decision-making.
- long-term neural data collection: Collection and storage of high-fidelity electroencephalography data across extended observation periods spanning months to years, replacing short-term clinical monitoring with continuous long-term tracking of daily neural patterns and seizure events.
- remote epilepsy care platforms: Digital health software capabilities enabling remote patient monitoring and secure transmission of brain activity records to attending clinicians, facilitating ongoing clinical evaluation and treatment adjustments outside traditional hospital settings.
- clinical diagnostic analytics: Processing and analysis of captured neural signals to provide objective data regarding seizure frequency and electroencephalographic events, assisting neurologists in addressing diagnostic limitations and tailoring medical therapies for refractory cases.
- clinical trial research: Execution of clinical research studies and observational trials to generate safety and efficacy evidence required for regulatory approvals, device optimization, and broader clinical adoption in global healthcare markets.
- patient monitoring accessory hardware: Design and delivery of external wearable hardware and charging accessories that power sub-scalp implants and transfer collected electroencephalography recordings from patients to cloud servers for clinical analysis.
Epiminder Ltd executive team
- Dr. Rohan J. Hoare Ph.D.CEO, MD & Director
- Prof. Mark Cook A.O.Founder & Chief Medical Officer
- Mr. Mark McLellanCFO & Company Secretary
- Dr. John HeasmanChief Operating Officer
- Mr. Toby McSweeneyCTO & VP of Quality